Annual CFO
-$21.25 M
+$19.37 M+47.69%
31 December 2023
Summary:
Cyclerion Therapeutics annual cash flow from operations is currently -$21.25 million, with the most recent change of +$19.37 million (+47.69%) on 31 December 2023. During the last 3 years, it has risen by +$51.24 million (+70.69%). CYCN annual CFO is now at all-time high.CYCN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.72 M
-$610.00 K-55.15%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly cash flow from operations is currently -$1.72 million, with the most recent change of -$610.00 thousand (-55.15%) on 30 September 2024. Over the past year, it has increased by +$5.22 million (+75.26%). CYCN quarterly CFO is now -55.15% below its all-time high of -$1.11 million, reached on 30 June 2024.CYCN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$6.23 M
+$5.22 M+45.57%
30 September 2024
Summary:
Cyclerion Therapeutics TTM cash flow from operations is currently -$6.23 million, with the most recent change of +$5.22 million (+45.57%) on 30 September 2024. Over the past year, it has increased by +$20.51 million (+76.69%). CYCN TTM CFO is now at all-time high.CYCN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.7% | +75.3% | +76.7% |
| 3 y3 years | +70.7% | +78.3% | +85.1% |
| 5 y5 years | +78.2% | +92.8% | +94.0% |
CYCN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +70.7% | -55.1% | +86.6% | at high | +85.2% |
| 5 y | 5 years | at high | +79.2% | -55.1% | +94.1% | at high | +94.0% |
| alltime | all time | at high | +79.2% | -55.1% | +95.0% | at high | +94.1% |
Cyclerion Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.72 M(+55.2%) | -$6.23 M(-45.6%) |
| June 2024 | - | -$1.11 M(-40.9%) | -$11.45 M(-32.2%) |
| Mar 2024 | - | -$1.87 M(+21.4%) | -$16.90 M(-20.4%) |
| Dec 2023 | -$21.25 M(-47.7%) | -$1.54 M(-77.8%) | -$21.25 M(-20.6%) |
| Sept 2023 | - | -$6.93 M(+5.8%) | -$26.75 M(-10.0%) |
| June 2023 | - | -$6.55 M(+5.5%) | -$29.73 M(-12.5%) |
| Mar 2023 | - | -$6.21 M(-11.8%) | -$33.99 M(-16.3%) |
| Dec 2022 | -$40.61 M(+11.2%) | -$7.04 M(-29.0%) | -$40.61 M(-3.8%) |
| Sept 2022 | - | -$9.91 M(-8.3%) | -$42.20 M(+5.0%) |
| June 2022 | - | -$10.82 M(-15.7%) | -$40.21 M(+15.2%) |
| Mar 2022 | - | -$12.84 M(+48.7%) | -$34.90 M(-4.4%) |
| Dec 2021 | -$36.52 M | -$8.63 M(+8.9%) | -$36.52 M(-12.9%) |
| Sept 2021 | - | -$7.92 M(+43.8%) | -$41.93 M(-14.5%) |
| June 2021 | - | -$5.51 M(-61.9%) | -$49.05 M(-15.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$14.46 M(+2.9%) | -$57.77 M(-20.3%) |
| Dec 2020 | -$72.49 M(-29.1%) | -$14.04 M(-6.7%) | -$72.49 M(-10.1%) |
| Sept 2020 | - | -$15.05 M(+5.8%) | -$80.61 M(-9.8%) |
| June 2020 | - | -$14.22 M(-51.3%) | -$89.38 M(-8.0%) |
| Mar 2020 | - | -$29.18 M(+31.7%) | -$97.12 M(-5.0%) |
| Dec 2019 | -$102.22 M(+4.8%) | -$22.16 M(-6.9%) | -$102.22 M(-1.0%) |
| Sept 2019 | - | -$23.81 M(+8.4%) | -$103.20 M(-1.4%) |
| June 2019 | - | -$21.97 M(-35.9%) | -$104.70 M(-0.6%) |
| Mar 2019 | - | -$34.27 M(+48.0%) | -$105.34 M(+8.0%) |
| Dec 2018 | -$97.50 M(+20.1%) | -$23.15 M(-8.5%) | -$97.50 M(+31.1%) |
| Sept 2018 | - | -$25.30 M(+11.9%) | -$74.35 M(+51.6%) |
| June 2018 | - | -$22.62 M(-14.4%) | -$49.05 M(+85.6%) |
| Mar 2018 | - | -$26.43 M | -$26.43 M |
| Dec 2017 | -$81.22 M | - | - |
FAQ
- What is Cyclerion Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual CFO year-on-year change?
- What is Cyclerion Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly CFO year-on-year change?
- What is Cyclerion Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics TTM CFO year-on-year change?
What is Cyclerion Therapeutics annual cash flow from operations?
The current annual CFO of CYCN is -$21.25 M
What is the all time high annual CFO for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual cash flow from operations is -$21.25 M
What is Cyclerion Therapeutics annual CFO year-on-year change?
Over the past year, CYCN annual cash flow from operations has changed by +$19.37 M (+47.69%)
What is Cyclerion Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CYCN is -$1.72 M
What is the all time high quarterly CFO for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly cash flow from operations is -$1.11 M
What is Cyclerion Therapeutics quarterly CFO year-on-year change?
Over the past year, CYCN quarterly cash flow from operations has changed by +$5.22 M (+75.26%)
What is Cyclerion Therapeutics TTM cash flow from operations?
The current TTM CFO of CYCN is -$6.23 M
What is the all time high TTM CFO for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high TTM cash flow from operations is -$6.23 M
What is Cyclerion Therapeutics TTM CFO year-on-year change?
Over the past year, CYCN TTM cash flow from operations has changed by +$20.51 M (+76.69%)